Raphael Pharmaceutical (RAPH) Current Assets (2020 - 2025)
Raphael Pharmaceutical (RAPH) posted Current Assets of $51000.0 for Q4 2025, up 920.0% sequentially from $5000.0 in Q3 2025, and up 104.0% YoY from $25000.0 in Q4 2024.
Raphael Pharmaceutical (RAPH) Current Assets (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has reported Current Assets for 6 years, with the latest figure at $51000.0 in Q4 2025.
- Quarterly Current Assets rose 104.0% year-over-year to $51000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $51000.0 (up 104.0% YoY) and the FY2025 annual result came in at $51000.0, up 104.0% from the prior year.
- Current Assets grew to $51000.0 in Q4 2025 per RAPH's latest filing, from $5000.0 in the prior quarter.
- Over five years, Current Assets peaked at $422000.0 in Q4 2021 and troughed at $5000.0 in Q3 2025.
- A 5-year average of $163388.9 and a median of $122500.0 in 2022 frame the typical range for Current Assets.
- The sharpest annual moves came in 2023 and 2025: Current Assets surged 237.82% in 2023, then slumped 89.8% in 2025.
- Over 5 years, Current Assets stood at $422000.0 in 2021, then slipped by 21.56% to $331000.0 in 2022, then declined by 28.4% to $237000.0 in 2023, then sank by 89.45% to $25000.0 in 2024, then soared by 104.0% to $51000.0 in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $51000.0, $5000.0, and $28000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 49,000.00 |
| Jun 30, 2024 | 126,000.00 |
| Mar 31, 2024 | 350,000.00 |
| Dec 31, 2023 | 237,000.00 |
| Sep 30, 2023 | 402,000.00 |
| Jun 30, 2023 | 118,000.00 |
| Mar 31, 2023 | 149,000.00 |
| Dec 31, 2022 | 331,000.00 |
| Sep 30, 2022 | 119,000.00 |
| Jun 30, 2022 | 196,000.00 |
| Mar 31, 2022 | 180,000.00 |
| Dec 31, 2021 | 422,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Dec 31, 2020 | 323,000.00 |